HEALTH● LOWSep 8 · Sep 8, 2026, 5:00 AM
Cholesterol drug setback casts doubt over multibillion-dollar race
CNBC · global
Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH39m agoPope Leo XIV sends message after surgery to Vatican conference , asks for prayersewtnnews.com · United StatesHEALTH39m agoMichelle Grattan | Labor reintroduces health insurance rebate | The Canberra Timescanberratimes.com.au · AustraliaHEALTH1h agoFDA advances peptide push to White HouseThe HillHEALTH1h agoThe average hospital stay is getting more expensive , new survey findsktvq.com · United States